News

Valneva SE, a specialty vaccine company focused on prevention of diseases with major unmet needs, and Dynavax Technologies Corporation, a biopharmaceutical company focused on developing…
Read More...

Valneva SE, a specialty vaccine company focused on prevention against diseases with major unmet needs,  announced a vaccine partnership with the UK government for its inactivated…
Read More...

Ansa Biotechnologies announced that it has raised $7.9 million in an oversubscribed Seed round of funding led by Horizons Ventures, with participation from Mubadala Capital, Humboldt…
Read More...

Pfizer Inc. and BioNTech SE announced that they have submitted an amended protocol to the U.S. Food and Drug Administration to expand the enrollment of their Phase 3 pivotal COVID-19…
Read More...

Harbour BioMed (HBM), a global, clinical-stage, innovative biopharmaceutical company announced a strategic partnership agreement with Hualan Genetic Engineering Co., Ltd (Hualan…
Read More...

Boehringer Ingelheim and Click Therapeutics announced they have entered into a collaboration for the development and commercialization of a prescription-based digital therapeutic. It…
Read More...

Global contract packaging organisation (CPO), Tjoapack is investing in its automated packaging capabilities to meet growing customer demand for pre-filled syringes and vials. The new…
Read More...

Integral Molecular announces the development of Humanized Chicken Antibody Technology (hCAT) and the incorporation of hCAT into the company's industry-leading MPS antibody discovery…
Read More...

Bayer and US-based Recursion Pharmaceuticals, Inc., a digital biology company industrializing drug discovery, have entered into a strategic collaboration agreement. The partnership will…
Read More...

Casma Therapeutics, Inc., a biotechnology company harnessing autophagy and the lysosome to design powerful new medicines, announced the completion of a $50 million Series B financing.…
Read More...

Ligand Pharmaceuticals Incorporated announces the acquisition of two privately held companies that strengthen and complement its OmniAb technology platform. Ligand acquired xCella…
Read More...

Pfizer Inc. and BioNTech SE announced preliminary preclinical data in mouse and non-human primate models from their BNT162b2 mRNA-based vaccine program against SARS-CoV-2, the virus…
Read More...

Jazz Pharmaceuticals plc announced that the company has signed a new research collaboration agreement with Redx Pharma plc to discover and develop drug candidates for two cancer targets…
Read More...

Takeda Pharmaceutical Company Limited announced results from the Phase 3 TOURMALINE-MM2 trial evaluating the addition of NINLARO (ixazomib) to lenalidomide and dexamethasone versus…
Read More...

GlaxoSmithKline plc and Innoviva, Inc. announced the US Food and Drug Administration (FDA) has approved a new indication for Trelegy Ellipta (fluticasone furoate / umeclidinium /…
Read More...

AgeX Therapeutics, Inc. a company focused on developing and commercializing innovative therapeutics for human aging, and Lineage Cell Therapeutics, Inc. a clinical-stage biotechnology…
Read More...

Exscientia and Huadong Medicine announced that the companies have entered into a co-development partnership to accelerate the discovery of breakthrough small-molecule therapeutics…
Read More...

SciBite, the award-winning semantic technology company, announced the launch of SciBiteAI, a state-of-the-art Artificial Intelligence software platform for leveraging machine learning…
Read More...

Exelixis, Inc. and NBE-Therapeutics announced a partnership to discover and develop multiple antibody-drug conjugates (ADCs) for oncology applications by leveraging NBE’s unique…
Read More...

AnGes, Inc. announced a collaboration agreement with Brickell Biotech, Inc. a clinical-stage pharmaceutical company, through which Brickell has the right to develop AnGes’ proprietary…
Read More...